Erin M B McNerny1, Dorothy T Buening2, Mohammad W Aref1, Neal X Chen3, Sharon M Moe4, Matthew R Allen5. 1. Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, United States. 2. Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, United States; Alma College, Alma, MI, United States. 3. Department of Medicine, Division of Nephrology, Indiana University School of Medicine, Indianapolis, IN, United States. 4. Department of Medicine, Division of Nephrology, Indiana University School of Medicine, Indianapolis, IN, United States; Roudebush Veterans Administration Medical Center, Indianapolis, IN, United States. 5. Department of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN, United States; Department of Medicine, Division of Nephrology, Indiana University School of Medicine, Indianapolis, IN, United States; Department of Biomedical Engineering, Indiana University Purdue University of Indianapolis, Indianapolis, IN, United States; Roudebush Veterans Administration Medical Center, Indianapolis, IN, United States. Electronic address: matallen@iupui.edu.
Abstract
BACKGROUND: Rodent studies of bone in chronic kidney disease have primarily relied on end-point examinations of bone microarchitecture. This study used longitudinal in vivo microcomputed tomography (in vivo μCT) to characterize the onset and progression of bone loss, specifically cortical porosity, in the Cy/+ rat of model of CKD. METHODS: Male CKD rats and normal littermates were studied. In vivo μCT scans of the right distal tibia repeated at 25, 30, and 35 weeks were analyzed for longitudinal changes in cortical and trabecular bone morphometry. In vitro μCT scans of the tibia and femur identified spatial patterns of bone loss across distal, midshaft and proximal sites. RESULTS: CKD animals had reduced BV/TV and cortical BV at all time points but developed cortical porosity and thinning between 30 and 35 weeks. Cortical pore formation was localized near the endosteal surface. The severity of bone loss was variable across bone sites, but the distal tibia was representative of both cortical and trabecular changes. CONCLUSIONS: The distal tibia was found to be a sensitive suitable site for longitudinal imaging of both cortical and trabecular bone changes in the CKD rat. CKD trabecular bone loss progressed through ~30 weeks followed by a sudden acceleration in cortical bone catabolism. These changes varied in timing and severity across individuals, and cortical bone loss and porosity progressed rapidly once initiated. The inclusion of longitudinal μCT in future studies will be important for both reducing the number of required animals and to track individual responses to treatment.
BACKGROUND: Rodent studies of bone in chronic kidney disease have primarily relied on end-point examinations of bone microarchitecture. This study used longitudinal in vivo microcomputed tomography (in vivo μCT) to characterize the onset and progression of bone loss, specifically cortical porosity, in the Cy/+ rat of model of CKD. METHODS: Male CKD rats and normal littermates were studied. In vivo μCT scans of the right distal tibia repeated at 25, 30, and 35 weeks were analyzed for longitudinal changes in cortical and trabecular bone morphometry. In vitro μCT scans of the tibia and femur identified spatial patterns of bone loss across distal, midshaft and proximal sites. RESULTS: CKD animals had reduced BV/TV and cortical BV at all time points but developed cortical porosity and thinning between 30 and 35 weeks. Cortical pore formation was localized near the endosteal surface. The severity of bone loss was variable across bone sites, but the distal tibia was representative of both cortical and trabecular changes. CONCLUSIONS: The distal tibia was found to be a sensitive suitable site for longitudinal imaging of both cortical and trabecular bone changes in the CKD rat. CKD trabecular bone loss progressed through ~30 weeks followed by a sudden acceleration in cortical bone catabolism. These changes varied in timing and severity across individuals, and cortical bone loss and porosity progressed rapidly once initiated. The inclusion of longitudinal μCT in future studies will be important for both reducing the number of required animals and to track individual responses to treatment.
Authors: Sebastian J Schambach; Simona Bag; Lothar Schilling; Christoph Groden; Marc A Brockmann Journal: Methods Date: 2009-08-23 Impact factor: 3.608
Authors: Sharon M Moe; Neal X Chen; Mark F Seifert; Rachel M Sinders; Dana Duan; Xianming Chen; Yun Liang; J Scott Radcliff; Kenneth E White; Vincent H Gattone Journal: Kidney Int Date: 2008-09-17 Impact factor: 10.612
Authors: Thomas L Nickolas; Emily Stein; Adi Cohen; Valerie Thomas; Ronald B Staron; Donald J McMahon; Mary B Leonard; Elizabeth Shane Journal: J Am Soc Nephrol Date: 2010-04-15 Impact factor: 10.121
Authors: Valentin David; Norbert Laroche; Benjamin Boudignon; Marie-Hélène Lafage-Proust; Christian Alexandre; Peter Ruegsegger; Laurence Vico Journal: J Bone Miner Res Date: 2003-09 Impact factor: 6.741
Authors: J H Waarsing; J S Day; J C van der Linden; A G Ederveen; C Spanjers; N De Clerck; A Sasov; J A N Verhaar; H Weinans Journal: Bone Date: 2004-01 Impact factor: 4.398
Authors: Sharon M Moe; Mark F Seifert; Neal X Chen; Rachel M Sinders; Xianming Chen; Dana Duan; Charles Henley; Dave Martin; Vincent H Gattone Journal: Nephrol Dial Transplant Date: 2009-03-03 Impact factor: 5.992
Authors: Samantha P Tippen; Corinne E Metzger; Elizabeth A Swallow; Spencer A Sacks; Joseph M Wallace; Matthew R Allen Journal: Bone Date: 2021-10-05 Impact factor: 4.398
Authors: Annabel Biruete; Corinne E Metzger; Neal X Chen; Elizabeth A Swallow; Curtis Vrabec; Erica L Clinkenbeard; Alexander J Stacy; Shruthi Srinivasan; Kalisha O'Neill; Keith G Avin; Matthew R Allen; Sharon M Moe Journal: Nephrol Dial Transplant Date: 2022-09-22 Impact factor: 7.186
Authors: Matthew R Allen; Joseph Wallace; Erin McNerney; Jeffry Nyman; Keith Avin; Neal Chen; Sharon Moe Journal: PLoS One Date: 2020-03-23 Impact factor: 3.240
Authors: Ursula Heilmeier; Gabby B Joseph; Courtney Pasco; Nhan Dinh; Soheyla Torabi; Karin Darakananda; Jiwon Youm; Julio Carballido-Gamio; Andrew J Burghardt; Thomas M Link; Galateia J Kazakia Journal: Front Endocrinol (Lausanne) Date: 2021-03-16 Impact factor: 6.055